Washington, DC - COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues. Treating people early in the course of infection with SARS-CoV-2, the virus that causes COVID-19, would speed their recovery, reduce the likelihood that they develop severe outcomes and reduce demand on the healthcare system, they write.

Washington, DC - A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was stopped indicated that the drug was not improving outcomes in COVID-19 patients. Final data and analyses of the trial, which was funded by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, will appear online November 9 in the Journal of the American Medical Association

Newark, New Jersey - The United States filed suit to halt the sale by a New Jersey entity of an unapproved “nano silver” product previously touted as a COVID-19 treatment, the Department of Justice announced Friday.

Los Angeles, California - Federal authorities Thursday morning arrested nine defendants, most of whom allegedly were involved in a sophisticated money laundering scheme that moved tens of millions of dollars derived from tax fraud and health care fraud schemes.

Fresno, California - A federal grand jury returned an eleven-count indictment today against Nahed Mishmish, 46, of Bakersfield, charging him with wire fraud, mail fraud and aggravated identity theft in a scheme that caused more than $900,000 in losses to the financial institutions, U.S. Attorney McGregor W. Scott announced.

Sacramento, California - A Florida man was indicted Thursday for distributing heroin, oxymorphone, oxycodone, and fentanyl as the narcotics vendor “chlnsaint” on Empire Market, a darknet hidden service, U.S. Attorney McGregor W. Scott announced.